Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Clinical trial NCT01665183 · COMPLETED

Trial details

NCT number: NCT01665183
Sponsor: Polaris Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors

Start date: 2012-09-01
Primary completion: 2016-02-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.